Balanced news tone
News Sentiment
TATVA sentiment intelligence
Tatva Chintan Pharma Chem Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
19 relevant articles
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-1.2% over one week, +0.5% over four weeks, trend inactive, and near fair-value range.
Tatva Chintan Pharma Chem to host investor meet on Jun 17
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
81/100 classification
One-week reaction
-1.2%
Price digesting
Trend fit
Trend inactive
0.5% over four weeks
Fair value
2.3%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
13
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem to host investor meet on Jun 17
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan FY26 Net Profit Surges to ₹420.54 Mn
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 19 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan Promoters Declare No Share Encumbrance for FY26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Earnings Update: Here's Why Analysts Just Lifted Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) Price Target To ₹1,390
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Tatva Chintan Pharma Schedules Q4FY26 Earnings Call on May 16, 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem Confirms Non-Large Corporate Status Under SEBI Framework
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem Limited Schedules Investor Meeting with OysterRock Capital for March 24, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- scanx.trade
HDFC Sky
Direct company coverage
Gas Supply Regulation Disclosure; Tatva Chintan Shares Slip 0.90%
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 16 Mar 2026 07:00
- Source
- HDFC Sky
scanx.trade
Direct company coverage
Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- scanx.trade
Moneycontrol.com
Direct company coverage
Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 23 Jan 2026 08:00
- Source
- Moneycontrol.com
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem Reports Strong Q3 FY26 Results with Revenue Growth of 52.9%
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 21 Jan 2026 08:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 21 Jan 2026 08:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jan 2026 08:00
- Source
- scanx.trade
Business Standard
Direct company coverage
Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Nov 2025 08:00
- Source
- Business Standard
simplywall.st
Direct company coverage
Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Oct 2025 07:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Tatva Chintan Pharma Chem - Goldman Sachs India portfolio slips, but 5 stocks rally 50-100% in 5 months
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Sep 2025 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Mukul Agrawal enters 7 new stocks including J&K Bank, Tatva Chintan; trims Sula, InfoBeans
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jul 2025 07:00
- Source
- Moneycontrol.com
simplywall.st
Direct company coverage
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jul 2025 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jul 2025 07:00
- Source
- simplywall.st